These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19548552)

  • 1. One pill makes you smaller: the demand for anti-obesity drugs.
    Cawley J; Rizzo JA
    Adv Health Econ Health Serv Res; 2007; 17():149-83. PubMed ID: 19548552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal.
    Blanck HM; Khan LK; Serdula MK
    Prev Med; 2004 Dec; 39(6):1243-8. PubMed ID: 15539063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
    Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
    Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How physician obesity specialists use drugs to treat obesity.
    Hendricks EJ; Rothman RB; Greenway FL
    Obesity (Silver Spring); 2009 Sep; 17(9):1730-5. PubMed ID: 19300434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-obesity drug use before professional treatment in Taiwan.
    Liou TH; Wu CH; Chien HC; Lin WY; Lee WJ; Chou P
    Asia Pac J Clin Nutr; 2007; 16(3):580-6. PubMed ID: 17704041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Expenditure Panel Survey: a valuable database for studying racial and ethnic disparities in prescription drug use.
    Wang J; Mullins CD; Zuckerman IH; Walker GD; Suda KJ; Yang Y; White-Means SI
    Res Social Adm Pharm; 2008 Sep; 4(3):206-17. PubMed ID: 18794032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' personal intake and prescription of weight loss products: are we practicing what we preach?
    La Puma J; Szapary P; Maki KC
    Arch Intern Med; 2004 Apr; 164(7):806-7. PubMed ID: 15078656
    [No Abstract]   [Full Text] [Related]  

  • 8. Are non-prescription medications needed for weight control?
    Bray GA
    Obesity (Silver Spring); 2008 Mar; 16(3):509-14. PubMed ID: 18239604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy for obesity.
    Udall JN; Licciardi DM; Svec F
    J La State Med Soc; 2005 Jan; 157 Spec No 1():S56-64. PubMed ID: 15751911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and costs of bariatric surgery and prescription weight-loss medications.
    Encinosa WE; Bernard DM; Steiner CA; Chen CC
    Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel anti-obesity drugs].
    Tripp B; Ludvik B
    Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medications for weight reduction.
    Bray GA
    Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological correlates of obesity in women.
    van der Merwe MT
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S14-8; discussion S31-2. PubMed ID: 17968432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of health insurance in explaining immigrant versus non-immigrant disparities in access to health care: comparing the United States to Canada.
    Siddiqi A; Zuberi D; Nguyen QC
    Soc Sci Med; 2009 Nov; 69(10):1452-9. PubMed ID: 19767135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence, behavior change, and visualization: a qualitative study of the experiences of taking an obesity medication.
    Ogden J; Sidhu S
    J Psychosom Res; 2006 Oct; 61(4):545-52. PubMed ID: 17011364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and labor market outcomes among legal immigrants to the United States from developing countries.
    Cawley J; Han E; Norton EC
    Econ Hum Biol; 2009 Jul; 7(2):153-64. PubMed ID: 19464240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, employment and wages in Europe.
    Garcia J; Quintana-Domeque C
    Adv Health Econ Health Serv Res; 2007; 17():187-217. PubMed ID: 19548553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
    Hutchinson NI; Ryder SW
    Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends in the use and costs of anti-obesity medications in England 1998-2005.
    Srishanmuganathan J; Patel H; Car J; Majeed A
    J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay for obesity pharmacotherapy.
    Doyle S; Lloyd A; Birt J; Curtis B; Ali S; Godbey K; Sierra-Johnson J; Halford JC
    Obesity (Silver Spring); 2012 Oct; 20(10):2019-26. PubMed ID: 22301901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.